POSVAX CO.

BiotechnologySeries BSeoul, South Koreaposvax.com

Latest round

Series B

Last raised

Jan 2021

Total raised

$19M

Investors

10

About POSVAX CO.

Established in 2018 and based in Seoul, South Korea, POSVAX CO. LTD operates as a biotech company, developing preventive vaccines for cervical cancer, head and neck cancer, RSV and Alzheimer's disease. In 2019, the company conducted preclinical trial of 9-valent HPV vaccine. The company possesses VLP Platform Technology, which is a next-generation vaccine technology that uses natural virus-like structures (VLPs) to improve the safety and efficacy of vaccines New technology to deliver drugs to specific targets using VLPs. This technology can be used to produce preventive vaccines such as the 9-valent HPV vaccine, alzheimer's disease vaccine and respiratory syncytial virus vaccine. By using the VLP platform, the company can develop novel anti-cancer drugs with excellent cell permeability.

Who invested in POSVAX CO.

10 investors across 2 rounds

See all investors in POSVAX CO.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jan 26, 2021

    Amount

    $14M

    Investors

    Locked

  2. Series A

    Aug 2, 2019

    Amount

    $4.1M

    Investors

    Locked

Questions about POSVAX CO.

Who invested in POSVAX CO.?

POSVAX CO. has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has POSVAX CO. raised?

POSVAX CO. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did POSVAX CO. last raise money?

POSVAX CO.'s most recent round on record is a Series B, in Jan 2021.

What does POSVAX CO. do?

Established in 2018 and based in Seoul, South Korea, POSVAX CO.

Where is POSVAX CO. headquartered?

POSVAX CO. is headquartered in Seoul, South Korea.

Which VCs invest in companies like POSVAX CO.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at POSVAX CO.'s stage. Their profiles are linked below.

Raising like POSVAX CO.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.